HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
E M Veys Selected Research
E M Veys Research Topics
Disease
16
Rheumatoid Arthritis
06/2009 - 03/2000
16
Spondylarthropathies
04/2005 - 03/2000
11
Inflammation (Inflammations)
06/2009 - 03/2000
8
Necrosis
06/2009 - 06/2000
7
Crohn Disease (Crohn's Disease)
10/2006 - 01/2001
5
Ankylosing Spondylitis
05/2003 - 05/2000
4
Arthritis (Polyarthritis)
06/2009 - 01/2001
4
Psoriatic Arthritis
08/2005 - 01/2001
3
Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2005 - 12/2002
2
Juvenile Arthritis (Juvenile Idiopathic Arthritis)
02/2006 - 07/2001
2
Synovitis
11/2005 - 01/2001
2
Ulcerative Colitis
02/2005 - 09/2001
2
Rheumatoid Nodule
05/2004 - 03/2000
2
Osteoarthritis
05/2004 - 06/2002
2
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2001 - 03/2000
1
Melanoma (Melanoma, Malignant)
06/2009
1
Renal Cell Carcinoma (Grawitz Tumor)
06/2009
1
Psoriasis (Pustulosis Palmaris et Plantaris)
08/2005
1
Demyelinating Diseases (Demyelinating Disease)
01/2005
1
Alopecia (Baldness)
09/2004
1
Hemolytic Anemia
09/2004
1
Joint Diseases (Joint Disease)
05/2004
1
Retropharyngeal Abscess
09/2003
1
Bacterial Infections (Bacterial Infection)
09/2003
1
Infections
09/2003
1
Tuberculosis (Tuberculoses)
09/2003
1
Dermatomyositis (Dermatopolymyositis)
12/2002
1
Connective Tissue Diseases (Connective Tissue Disease)
10/2002
1
Uveitis
05/2002
1
Low Back Pain (Lumbago)
12/2000
1
Ulcer
09/2000
1
Pain (Aches)
06/2000
Drug/Important Bio-Agent (IBA)
13
Infliximab (Remicade)
FDA Link
06/2009 - 06/2000
11
Antibodies
IBA
02/2006 - 12/2002
8
Proteins (Proteins, Gene)
FDA Link
06/2009 - 09/2000
7
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2009 - 01/2001
5
Cytokines
IBA
06/2009 - 05/2001
4
Rheumatoid Factor
IBA
09/2005 - 12/2004
4
Monoclonal Antibodies
IBA
03/2002 - 03/2000
3
Biomarkers (Surrogate Marker)
IBA
06/2009 - 10/2002
3
Antinuclear Antibodies
IBA
06/2009 - 09/2004
3
Etanercept (Enbrel)
FDA Link
06/2009 - 01/2001
3
Peptides (Polypeptides)
IBA
02/2006 - 02/2005
3
Biological Products
IBA
09/2005 - 01/2001
3
Autoantibodies
IBA
12/2004 - 10/2001
2
Interleukins
IBA
06/2009 - 05/2001
2
Anti-Citrullinated Protein Antibodies
IBA
08/2005 - 02/2005
2
Scavenger Receptors (Scavenger Receptor)
IBA
02/2005 - 04/2001
2
Messenger RNA (mRNA)
IBA
09/2000 - 03/2000
2
Catenins
IBA
09/2000 - 03/2000
2
Cadherins (E-Cadherin)
IBA
09/2000 - 03/2000
1
Collagen Type II (Type II Collagen)
IBA
06/2009
1
Nuclear Antigens (Extractable Nuclear Antigens)
IBA
06/2009
1
Alginates
IBA
06/2009
1
Immunoglobulin M (IgM)
IBA
06/2009
1
Sorafenib (BAY 43-9006)
FDA Link
06/2009
1
N 30
IBA
06/2009
1
Genetic Markers (Genetic Marker)
IBA
10/2006
1
Nerve Growth Factors (Neurotrophins)
IBA
11/2005
1
Enzymes
IBA
09/2005
1
cyclic citrullinated peptide
IBA
08/2005
1
Complementary DNA (cDNA)
IBA
05/2004
1
RNA (Ribonucleic Acid)
IBA
05/2004
1
Epitopes
IBA
05/2004
1
Immunoglobulin A (IgA)
IBA
05/2003
1
Cell Adhesion Molecules
IBA
12/2002
1
Chondroitin
IBA
06/2002
1
Integrins
IBA
11/2001
1
Interleukin-2 (IL2)
IBA
09/2001
1
Interleukin-4 (Interleukin 4)
IBA
05/2001
1
Interleukin-10 (Interleukin 10)
IBA
05/2001
1
Interferon-gamma (Interferon, gamma)
IBA
05/2001
1
HLA-B27 Antigen (HLA B27 Antigen)
IBA
12/2000
1
C-Reactive Protein
IBA
06/2000
1
Autoantigens
IBA
06/2000
1
Immunoglobulin G (IgG)
IBA
05/2000
1
Glycoproteins (Glycoprotein)
IBA
03/2000
1
beta Catenin
IBA
03/2000
1
alpha Catenin (alpha E-Catenin)
IBA
03/2000
1
gamma Catenin (Plakoglobin)
IBA
03/2000
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
03/2000
Therapy/Procedure
2
Therapeutics
01/2005 - 01/2001
1
Immunomodulation
01/2005
1
Activities of Daily Living (ADL)
07/2001
1
Intravenous Infusions
06/2000